Market Research Report
Asia-pacific Polymerase Chain Reaction Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||837251|
|Published||Content info||88 Pages
Delivery time: 2-3 business days
|Asia-pacific Polymerase Chain Reaction Market Forecast 2019-2027|
|Published: May 13, 2019||Content info: 88 Pages||
The global polymerase chain reaction market by Asia Pacific region had generated a revenue of $XX million in 2018 & is projected to reach $XX million by 2027, at a CAGR of 6.73%. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027. The advent of easy to use PCR devices will open avenues for the PCR market.
The key factors promoting the market growth in the region include growing geriatric population, increasing incidences of infectious diseases which are boosting the growth of the region. The countries of China, India, Japan, South Korea, Australia and the Rest of APAC are taken into consideration for the market study. India is expected to be the fastest growing region in the market owing to the rise of endemic diseases coupled with the rising geriatric population is fueling the growth of the market in the coming years.
Danaher Corporation, Biomerieux SA, Siemens Healthineers, Nano Biosys Inc., F. Hoffman La Roche Ltd., Becton Dickinson Biosciences Systems and Reagents Inc., Agilent Technologies Inc., Qiagen N.V., Thermo Fisher Scientific Inc., MDXhealth Corporation, Bio-Rad Technologies Inc., Fluidigm Corporation, Abbott Laboratories, Tahara Bio Inc., and Pacific Biosciences of California, Inc. are the companies which are mentioned in the report.